Urteste SA (WAR:URT) — Market Cap & Net Worth
Market Cap & Net Worth: Urteste SA (URT)
Urteste SA (WAR:URT) has a market capitalization of $18.06 Million (zł65.62 Million) as of May 22, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #25465 globally and #260 in its home market, demonstrating a 1.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Urteste SA's stock price zł43.00 by its total outstanding shares 1526080 (1.53 Million). Analyse cash flow conversion of Urteste SA to see how efficiently the company converts income to cash.
Urteste SA Market Cap History: 2021 to 2026
Urteste SA's market capitalization history from 2021 to 2026. Data shows change from $40.28 Million to $18.06 Million (-16.65% CAGR).
Urteste SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Urteste SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
22.21x
Urteste SA's market cap is 22.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $33.18 Million | $3.00K | -$4.06 Million | 11059.98x | N/A |
| 2023 | $45.78 Million | $1.33 Million | -$5.59 Million | 34.42x | N/A |
| 2024 | $39.98 Million | $1.80 Million | -$3.63 Million | 22.21x | N/A |
Competitor Companies of URT by Market Capitalization
Companies near Urteste SA in the global market cap rankings as of May 22, 2026.
Key companies related to Urteste SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.03 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #414 globally with a market cap of $66.20 Billion USD.
- argenx NV ADR (NASDAQ:ARGX): Ranked #577 globally with a market cap of $45.97 Billion USD.
- UCB S.A. UNSP.ADR 1/2 (F:UNC0): Ranked #598 globally with a market cap of $44.84 Billion USD ( €38.35 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.03 Billion | $433.54 |
| #414 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $66.20 Billion | $642.59 |
| #577 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
| #598 | UCB S.A. UNSP.ADR 1/2 | F:UNC0 | $44.84 Billion | €120.00 |
Urteste SA Historical Marketcap From 2021 to 2026
Between 2021 and today, Urteste SA's market cap moved from $40.28 Million to $ 18.06 Million, with a yearly change of -16.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł18.06 Million | +10.26% |
| 2025 | zł16.38 Million | -59.03% |
| 2024 | zł39.98 Million | -12.66% |
| 2023 | zł45.78 Million | +37.97% |
| 2022 | zł33.18 Million | -17.62% |
| 2021 | zł40.28 Million | -- |
End of Day Market Cap According to Different Sources
On May 22nd, 2026 the market cap of Urteste SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.06 Million USD |
| MoneyControl | $18.06 Million USD |
| MarketWatch | $18.06 Million USD |
| marketcap.company | $18.06 Million USD |
| Reuters | $18.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Urteste SA
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.